Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2019AgingOpen Access

m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRuichao ChaiCapital Medical UniversityFWFan WuHarbin Medical UniversityQWQixue WangTianjin Medical University General Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chai et al. (2019) studied this question.

synapsesocial.com/papers/6a8968a9b1e5d05ea8ec6ecehttps://doi.org/10.18632/aging.101829
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia2017 · 208 citations
  2. 2Interactions, localization, and phosphorylation of the m<sup>6</sup>A generating METTL3–METTL14–WTAP complex2018 · 437 citations
  3. 3Increased N6‐methyladenosine causes infertility is associated with FTO expression2018 · 143 citations
  4. 4RNA N6-methyladenosine modification in cancers: current status and perspectives2018 · 939 citations
  5. 5METTL3-mediated m6A modification is required for cerebellar development2018 · 312 citations